Featured Stories

Atrial fibrillation (AF) is a common heart rhythm disorder affecting millions of people worldwide. In Europe alone, over 6 million individuals live with this condition. AF can significantly...

Following treatment with TheraSphere Y90 Glass Microspheres then surgery, Griffiths is back to enjoying life again.

While heart disease is often perceived as a male health issue, it is a significant health concern for women in Europe as well. Indeed, women are at a higher risk for specific types of heart...

Survey among 3,000 people with chronic pain in Germany, Italy, and the United Kingdom underscores the mental and emotional challenges faced by those living with the condition. With one in five...

Boston Scientific has announced the appointment of Angelo Auricchio, M.D., Ph. D., as chief medical officer (CMO) of the Rhythm Management business in Europe, Middle East, and Africa (EMEA). A...

Amidst the societal digitisation of the past decade, digital health solutions have emerged as powerful tools to bridge gaps in healthcare access, highlighting the importance of making these...

Improvements in a therapy that targets liver tumours while limiting radiation exposure to healthy surrounding tissue are significantly increasing the survival time of patients with liver cancer,...

The medical team at Panorama Hospital in Cape Town, South Africa. ​ The digital solution developed by Boston Scientific is bridging the geographic gap in cardiac care, reaching patients from...

A new study published in BMJ Open (BMJ Open) suggests that using the FARAPULSE™ Pulsed Field Ablation (PFA) System is not only a clinically effective treatment for paroxysmal atrial fibrillation...

6 June 2024 A 20-year energy reduction strategy helped Boston Scientific get ready to adopt net-zero targets under the Science Based Targets initiative and push forward on its decarbonisation...